Hypertension is a serious health issue that affects people all over the world and remains a significant public health concern as it is linked to morbidity, mortality and economic effects on society. Premature birth, intrauterine foetal death, growth retardation and abruption placentae are all elevated hazards for pregnant women with high blood pressure. Hence, aim of this study is to evaluate prescribing pattern of antihypertensive drug in pregnancy in a tertiary care hospital. A prospective observational study was carried out in NMCH and RC for a period of 3 months from May to July. All the patients who were presented to the obstetrics and gynaecology out-patient department of the hospital were reviewed daily to identify the patients diagnosed with Pregnancy induced hypertension. A suitably designed data collection form was utilised to gather information on the patients, including their age, gestational age, gravida, parity, blood pressure status, history of previous deliveries, comorbidities and treatments received. The results indicated that, majority of participants were diagnosed with Pregnancy induced hypertension (91.66 %), followed by participants diagnosed with Preeclampsia (16.66%) and subjects corresponding to Eclampsia diagnosis (8.33%). most of the subjects (88.32 %) received monotherapy. It was found that Labetalol (68.33 %), was most common antihypertensive drug prescribed, followed by Nifidipine given to 11.66 % patients, Methyldopa prescribed to 8.33 % patients. Asthma was the major comorbidity associated with hypertension during pregnancy and was found (15%), followed by Gestational diabetes (3.33%) and Hypothyroidism (3.33%).
Loading....